Finland· FI-REL-REL4544
Hiberix
A haemophilus influenzae b, gereinigtes antigen konjugiert product containing haemophilus influenzae b polysaccharide,tetanus toxoid conjugate, registered in Finland by GlaxoSmithKline Biologicals SA. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Haemophilus influenzae b, gereinigtes antigen konjugiert is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AG01 (haemophilus influenzae b, gereinigtes antigen konjugiert), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Haemophilus influenzae b, gereinigtes antigen konjugiert · ATC J07AG01
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Haemophilus influenzae B polysaccharide,tetanus toxoid conjugate
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- Finland (FI)
- ATC code
- J07AG01
- ATC class
- Haemophilus influenzae B, gereinigtes Antigen konjugiert
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AG01
Haemophilus influenzae b, gereinigtes antigen konjugiert, as other registers publish it.
- FinlandAct-HibSanofi Winthrop Industrie
- NorwayAct-HibSanofi Winthrop Industrie
- PolandAct-HiBSanofi Winthrop Industrie
- NorwayAct-HIBSanofi Pasteur
- CanadaACT-HIBSANOFI PASTEUR LIMITED
- BelgiumAct-HIB 10 µg/0.5 mlSanofi Winthrop Industrie
- NetherlandsAct-Hib, 10 microgram/0,5 ml poeder en oplosmiddel voor oplossing voor injectieSanofi Winthrop Industrie
- SwitzerlandHiberix
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f384a45-3270-4b5e-8e05-45b51bda162e GET /v1/drugs/5f384a45-3270-4b5e-8e05-45b51bda162e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "haemophilus influenzae tyyppi b konjugaattirokote",
"ma_number": "12456",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL4544",
"authorised_at": "1997-12-01"
}See everything about haemophilus influenzae b, gereinigtes antigen konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.